The anticancer drug Dp44mT inhibits T-cell activation and CD25 through a copper-dependent mechanism

Justin H. Gundelach, Ajay A. Madhavan, Peter J. Wettstein, Richard J. Bram

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Fingerprint Dive into the research topics of 'The anticancer drug Dp44mT inhibits T-cell activation and CD25 through a copper-dependent mechanism'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences